Know Cancer’s Next Move: Using ctDNA to guide treatment decisions in patients with GI Cancer
Watch Video
Resource Library
-
-
ctDNA in GI Cancers
Applications of personalized ctDNA testing to optimize treatment decisions in patients with GI cancers, presented by Dr. Adham Jurdi, MD
Watch Video
-
Prospera ICD-10 Codes
Read Article
-
Vistara ICD-10 Codes
Read Article
-
Have a question or comment?
Contact Us -
Signatera ICD-10 Codes
Read Article
-
Renasight ICD-10 Codes
Read Article
-
Empower ICD-10 Codes
Read Article
-
Panorama ICD-10 Codes
Read Article
-
Horizon ICD-10 Codes
Read Article
-
Empower ICD-10 Codes
Read Article
-
Patient Medical Records Release Form
Read More
-
CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer
Read More
-
Detection of molecular residual disease using personalized circulating tumor DNA assay in colorectal cancer patients undergoing resection of
Read More
-
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stage I to III Colorectal Cancer
Read More
-
A multicenter, prospective observational study to evaluate the impact of circulating tumor DNA guided therapy on patients with colorectal ca
Read More
-
ctDNA clearance and radiographic resolution of disease in response to dual checkpoint inhibition in metastatic microsatellite stable colorec
Read More
-
Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, towards assessment of adjuvant therapy effi
Read More
-
Early detection of circulating tumor DNA post-operatively enables discovery of resectable metastatic disease in a patient with colon cancer
Read More
-
Post-operative ctDNA monitoring in stage I colon cancer: A case report
Read More
-
Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair d
Read More
-
Loading More...
